Aligos Therapeutics (ALGS) Enterprise Value: -3.781M

Aligos Therapeutics, Inc. (ALGS)

2.15 -0.42 (-16.34%) USD | NASDAQ | Nov 11, 16:00

2.09 -0.06 (-2.79%) After-Hours: 19:59

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.

Date	Value
November 10, 2026	-3.781M
November 09, 2026	4.842M
November 06, 2026	5.592M
November 05, 2026	8.341M
November 04, 2026	11.53M
November 03, 2026	9.841M
November 02, 2026	8.904M
October 30, 2026	10.15M
October 29, 2026	11.59M
October 28, 2026	12.47M
October 27, 2026	9.778M
October 26, 2026	9.216M
October 23, 2026	10.03M
October 22, 2026	10.28M
October 21, 2026	11.15M
October 20, 2026	11.59M
October 19, 2026	10.40M
October 16, 2026	10.53M
October 15, 2026	13.84M
October 14, 2026	12.84M
October 13, 2026	14.59M
October 12, 2026	14.71M
October 09, 2026	13.53M
October 08, 2026	13.34M
October 07, 2026	13.40M

Date	Value
October 06, 2026	13.78M
October 05, 2026	13.90M
October 02, 2026	14.78M
October 01, 2026	14.53M
September 30, 2026	15.34M
September 29, 2026	8.132M
September 28, 2026	7.633M
September 25, 2026	7.446M
September 24, 2026	7.695M
September 23, 2026	7.758M
September 22, 2026	8.506M
September 21, 2026	7.321M
September 18, 2026	5.762M
September 17, 2026	5.325M
September 16, 2026	4.577M
September 15, 2026	4.203M
September 14, 2026	4.514M
September 11, 2026	5.637M
September 10, 2026	6.323M
September 09, 2026	7.383M
September 08, 2026	9.005M
September 04, 2026	11.81M
September 03, 2026	11.87M
September 02, 2026	11.81M
September 01, 2026	11.06M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks